INNODIA INC has a total of 27 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Brazil, Canada and China. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are MEDEA RES SRL, HU LIFANG and PURETECH LYT INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Brazil | 4 | |
#2 | Canada | 4 | |
#3 | China | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | United States | 4 | |
#6 | WIPO (World Intellectual Property Organization) | 3 | |
#7 | Mexico | 2 | |
#8 | Australia | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Chapal Nicolas | 9 |
#2 | Ribes Gerard | 8 |
#3 | Mioskowski Charles | 7 |
#4 | Vezeau Claude | 6 |
#5 | Bellini Francesco | 6 |
#6 | Prentki Marc | 6 |
#7 | Mcnicol Patricia | 5 |
#8 | Jette Lucie | 4 |
#9 | Wagner Alain | 4 |
#10 | Coquelet Claude | 4 |
Publication | Filing date | Title |
---|---|---|
WO2008154750A1 | Conversion of isoleucine to 4-hydroxyisoleucine by microorganisms | |
WO2008154743A1 | Methods for the synthesis of 4-hydroxyisoleucine, stereoisomers and analogs thereof | |
US2010048545A1 | Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity | |
CN101252926A | Compounds and compositions for use in the prevention and treatment of obesity and related syndromes | |
CN101193852A | Analogs of 4-hydroxyisoleucine and uses thereof | |
WO2005039626A2 | Use of hydroxylated amino acids for treating diabetes |